Clinical Trial Update: 0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant [Phase 4]

View source ↗

Summary

Phase 4 study comparing two atropine doses (0.6 mg vs 1.2 mg) given with neostigmine 2.5 mg to evaluate heart-rate response in patients receiving a muscle relax…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia

Drugs mentioned

• Atropine (atropine)
• Neostigmine (neostigmine)

Snippet

Sponsor: Mahidol University | Conditions: Bradycardia, Neostigmine Adverse Reaction | Phase 4 | Status: COMPLETED